Cera Sanitaryware Limited has filed a regulatory disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 regarding the exercise of employee stock options under the 'Cera Sanitaryware - Employee Stock Option Scheme 2024' (ESOS 2024).

Key Details of Option Exercise

  • Options Exercised: 2109 options exercised on 17th June, 2026
  • Source Grant: Options were granted on 5th June, 2024 (Grant I) totaling 14,950 options
  • Vesting Date: Options vested on 5th June, 2026 (2nd anniversary from grant date)
  • Total Vested Options: 2244 options vested (15% of the 14,950 options granted)
  • Exercise Price: ₹5 per option
  • Total Proceeds: ₹10,545 realized from the exercise
  • Share Transfer: CERA Sanitaryware Employees Welfare Trust is in process of transferring equity shares to option grantees

Capital Structure Impact

There will be no change in the paid-up equity share capital of the Company as the shares have been sourced from the secondary market. No additional shares have been issued as a result of this option exercise.

Scheme Details

  • Scheme Name: Cera Sanitaryware - Employee Stock Option Scheme 2024
  • Compliance: Scheme is in terms of SEBI (SBEB) Regulations, 2021
  • Total Shares Covered: 14,950 equity shares of face value ₹5 each
  • Exercise Period: Maximum of 5 years commencing from the relevant date of vesting
  • Vesting Schedule:
  • 1st anniversary: 10% of options granted
  • 2nd anniversary: 15% of options granted
  • 3rd anniversary: 15% of options granted
  • 4th anniversary: 30% of options granted
  • 5th anniversary: 30% of options granted
  • Minimum Vesting Period: 1 year
  • Maximum Vesting Period: 5 years from Grant Date

Additional Information

  • Each vested option entitles the eligible employee to 1 fully paid-up equity share of the Company
  • Options are granted based on eligibility criteria mentioned in the Scheme
  • Grants are governed by vesting schedule, performance conditions (KPI), and other terms detailed in the letter of grant
  • No options lapsed, no variations of terms, and no subsequent changes or cancellations reported
  • Diluted earnings per share impact: Not applicable